Public health expert tells Spokane committee harm reduction reduces overdose and infectious disease; debate surfaces over safe‑smoking supplies

A public‑health briefing to Spokane’s Public Safety and Community Health Committee on May 5 argued that harm‑reduction measures — including syringe services, naloxone distribution and safer‑smoking supplies — reduce overdose deaths, cut infectious‑disease transmission and increase entry into treatment.

Doctor Menriquez opened the briefing with a personal example to illustrate the harm‑reduction pathway to recovery: a former injection user who survived multiple overdoses, later completed recovery work and now helps others as a care coordinator. Menriquez framed harm reduction with a definition from the National Harm Reduction Coalition and summarized evidence from the University of Washington’s Addiction Drug and Alcohol Institute (ADAI) and the Centers for Disease Control.

Key evidence cited

Menriquez summarized peer‑reviewed and public‑health findings that syringe‑service participants are more likely to enter treatment and to stop injecting, that programs can reduce HIV and hepatitis‑C infections by about 50 percent when combined with medication‑assisted treatment, and that naloxone distributed to people who use drugs prevents overdose deaths. "Harm reduction is a set of practices ... aimed at reducing negative consequences associated with drug use," Menriquez said, citing the National Harm Reduction Coalition.

On safer smoking supplies — a subject of local debate — Menriquez said published studies and state analyses suggest smoking (when substituted for injection) can reduce overdose risk because it allows users more dose control, and he cited local and national pilot programs that distribute pipes and associated hygiene supplies along with naloxone. He reported that local distribution efforts and student groups had provided more than 1,500 doses of naloxone to high‑risk community members.

Public questions and critiques

Council members raised skeptical studies and local operational questions. Councilmember Capriar cited a Journal of Public Economics study that she said found a 21.6% increase in opioid‑related mortality near syringe‑exchange programs; Menriquez answered that later evaluations and re‑analyses show that early apparent associations are generally explained by selection bias (higher‑risk populations using the services), and he pointed to more recent ADAI and CDC findings supporting the public‑health benefits of syringe programs.

Several council members asked practical questions about who operates safe‑supply and safer‑smoking distributions locally. Menriquez said the health district historically provides needle exchange and that CHAS Health and student groups have assisted with distribution; he also said CHAS stopped one safer‑smoking distribution after a short period. During committee discussion, staff said CHAS shut down a temporary safe‑smoking program after about 30 days and that the health district was not currently operating safer‑smoking distributions.

On the question whether displacement or sweeps increase overdose risk, Menriquez cited modeling studies that found routine displacement of unsheltered people worsened health outcomes over time and might raise overdose deaths in the affected population.

Ending

Committee members thanked Menriquez for the briefing and asked staff to clarify which agencies will operate safer‑smoking and supply distributions going forward. The committee recorded no vote. Menriquez recommended expanding naloxone saturation among people who use drugs as a near‑term public‑health strategy.